# 4-phenylbutyric acid improves sepsis-induced cardiac dysfunction by modulating amino acid metabolism and lipid metabolism via Comt/Ptgs2/Ppara

**Authors:** Yuanqun Zhou, Yu Zhu, Yue Wu, Xinming Xiang, Xingnan Ouyang, Liangming Liu, Tao Li

PMC · DOI: 10.1007/s11306-024-02112-3 · Metabolomics · 2024-04-19

## TL;DR

This study shows that 4-phenylbutyric acid (PBA) helps reduce heart damage in sepsis by affecting amino acid and lipid metabolism through specific genes.

## Contribution

The study identifies Comt/Ptgs2/Ppara as key targets of PBA in protecting the heart during sepsis.

## Key findings

- PBA alleviated sepsis-induced cardiac damage in a mouse model.
- Metabolomics revealed 28 metabolites involved in PBA's therapeutic effects.
- Network pharmacology identified 7 key targets, including Comt, Ptgs2, and Ppara.

## Abstract

Cardiac dysfunction after sepsis the most common and severe sepsis-related organ failure. The severity of cardiac damage in sepsis patients was positively associated to mortality. It is important to look for drugs targeting sepsis-induced cardiac damage. Our previous studies found that 4-phenylbutyric acid (PBA) was beneficial to septic shock by improving cardiovascular function and survival, while the specific mechanism is unclear.

We aimed to explore the specific mechanism and PBA for protecting cardiac function in sepsis.

The cecal ligation and puncture-induced septic shock models were used to observe the therapeutic effects of PBA on myocardial contractility and the serum levels of cardiac troponin-T. The mechanisms of PBA against sepsis were explored by metabolomics and network pharmacology.

The results showed that PBA alleviated the sepsis-induced cardiac damage. The metabolomics results showed that there were 28 metabolites involving in the therapeutic effects of PBA against sepsis. According to network pharmacology, 11 hub genes were found that were involved in lipid metabolism and amino acid transport following PBA treatment. The further integrated analysis focused on 7 key targets, including Comt, Slc6a4, Maoa, Ppara, Pparg, Ptgs2 and Trpv1, as well as their core metabolites and pathways. In an in vitro assay, PBA effectively inhibited sepsis-induced reductions in Comt, Ptgs2 and Ppara after sepsis.

PBA protects sepsis-induced cardiac injury by targeting Comt/Ptgs2/Ppara, which regulates amino acid metabolism and lipid metabolism. The study reveals the complicated mechanisms of PBA against sepsis.

The online version contains supplementary material available at 10.1007/s11306-024-02112-3.

## Linked entities

- **Genes:** COMT (catechol-O-methyltransferase) [NCBI Gene 1312], PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465], SLC6A4 (solute carrier family 6 member 4) [NCBI Gene 6532], MAOA (monoamine oxidase A) [NCBI Gene 4128], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], TRPV1 (transient receptor potential cation channel subfamily V member 1) [NCBI Gene 7442]
- **Chemicals:** 4-phenylbutyric acid (PubChem CID 4775)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, SLC6A4 (solute carrier family 6 member 4) [NCBI Gene 6532] {aka 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, COMT (catechol-O-methyltransferase) [NCBI Gene 1312] {aka HEL-S-98n}, TRPV1 (transient receptor potential cation channel subfamily V member 1) [NCBI Gene 7442] {aka VR1}, MAOA (monoamine oxidase A) [NCBI Gene 4128] {aka BRNRS, MAO-A}
- **Diseases:** organ failure (MESH:D009102), sepsis (MESH:D018805), septic shock (MESH:D012772), Cardiac dysfunction (MESH:D006331)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11031492/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11031492/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC11031492/full.md

---
Source: https://tomesphere.com/paper/PMC11031492